InvestorsHub Logo

DewDiligence

02/21/18 8:20 AM

#217394 RE: oc631 #208669

ABBV/NBIX—Phase-3 trials of Elagolix hit all endpoints in uterine fibroids:

https://finance.yahoo.com/news/abbvie-announces-positive-topline-results-130000091.html